|
|
| Current
Issue: April-June 2021
| Vol 16 | Issue 2 |
|
|
| Original Article |
|
| Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials |
|
 |
|
| Ahmed Abu-Zaid, Aseel Khalid Aljaili, Amnah Althaqib, Fatima Adem, Doaa Ali Alhalal, Amena Faiq Almubarak, Saud Musaab Aldughaither, Sarah Ali Alghabban, Ghaidaa Alfaraj, Ahmed Taher Masoud, Nujud Abdullah Alsuhaibani |
|
|
AIM: We conducted this systematic review and meta-analysis to investigate the efficacy and safety of gefapixant, a novel P2X3 receptor antagonist, in patients with chronic cough.
METHODS:... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
|
|
|
| Original Article |
|
| A visual analog scale for the assessment of mild sleepiness in patients with obstructive sleep apnea and healthy participants |
|
 |
|
| Yousef D Alqurashi, Aleksander Dawidziuk, Abdullah Alqarni, Julia Kelly, James Moss, Michael I Polkey, Mary J Morrell |
|
|
MOTIVATION: Studies have shown poor clinical effectiveness of the Epworth Sleepiness Scale (ESS) due to its ambiguity of items and cultural applicability. This study aimed to investigate the ... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
|
|
|
| Original Article |
|
| Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers |
|
 |
|
| Daniel Thompson, Luke A Perry, Jesse Renouf, Domagoj Vodanovich, Adele Hwee Hong Lee, Jahan Dimiri, Gavin Wright |
|
|
BACKGROUND/OBJECTIVE: Given the poor overall survival (OR) and progression-free survival (PFS) rates for lung cancers managed with surgical resection, there is a need to identify the prognost... |
|
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Read more.... |
|
| |
|
|
